BSEUltracab (India) LtdHighNeutral
Announced Mon, 10 Nov · 18:27 IST

Please find attached herewith the outcome of the Board meeting held today i.e., Monday, November 10, 2025 under Regulation 30 of the SEBI LODR Regulations, 2015

Ebitda Margin CompressionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ultracab (India) Ltd's Board on November 10, 2025 approved unaudited standalone financial results for Q2 and H1 FY26 ended September 30, 2025. Q2 FY26 revenue from operations grew about 3.8% YoY to Rs 5,766.05 lakhs, while H1 FY26 revenue rose roughly 8.8% YoY to Rs 11,779.53 lakhs. However, profitability weakened sharply — Q2 PAT fell to Rs 151.97 lakhs from Rs 296.44 lakhs a year ago, and H1 PAT dropped around 30% to Rs 322.24 lakhs from Rs 462.38 lakhs. EBITDA margin compressed materially from about 8.6% in H1 FY25 to roughly 5.7% in H1 FY26, hit by higher material and other expenses even as finance costs came down. EPS halved to Rs 0.26 in H1 FY26 from Rs 0.49 in H1 FY25. The statutory auditors (Bhavin Associates) issued an unqualified Limited Review Report.

Likely market impact

Despite top-line growth, the sharp PAT decline and EBITDA margin compression signal profitability stress for shareholders. The stock may face near-term pressure given the significant earnings drop, though revenue growth and a clean audit offer some comfort.